Fluvoxamine reduces levodopa induced dyskinesia in the MPTP-treated common marmosets

被引：0
作者：
Johnston, LC [1 ]
Rose, A [1 ]
McCreary, AC [1 ]
Jenner, P [1 ]
机构：
[1] Kings Coll London, Guys Kings & St Thomas Sch Biomed Sci, Neurodegenerat Dis Res Ctr, London SE1 1UL, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2003年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
198P
引用
收藏
页码：U99 / U99
页数：1
相关论文
共 7 条
  • [1] CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443
  • [2] SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study
    Dell'Agnello, G
    Ceravolo, R
    Nuti, A
    Bellini, G
    Piccinni, A
    D'Avino, C
    Dell'Osso, L
    Bonuccelli, U
    [J]. CLINICAL NEUROPHARMACOLOGY, 2001, 24 (04) : 221 - 227
  • [3] LEVODOPA-INDUCED DYSKINESIAS ARE IMPROVED BY FLUOXETINE
    DURIF, F
    VIDAILHET, M
    BONNET, AM
    BLIN, J
    AGID, Y
    [J]. NEUROLOGY, 1995, 45 (10) : 1855 - 1858
  • [4] Pharmacokinetics of selective serotonin reuptake inhibitors
    Hiemke, C
    Härtter, S
    [J]. PHARMACOLOGY & THERAPEUTICS, 2000, 85 (01) : 11 - 28
  • [5] Activation of 5-HT1A but not 5-HT1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation
    Kannari, K
    Yamato, H
    Shen, H
    Tomiyama, M
    Suda, T
    Matsunaga, M
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 76 (05) : 1346 - 1353
  • [6] De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset
    Pearce, RKB
    Banerji, T
    Jenner, P
    Marsden, CD
    [J]. MOVEMENT DISORDERS, 1998, 13 (02) : 234 - 241
  • [7] The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa
    Rampello, L
    Chiechio, S
    Raffaele, R
    Vecchio, I
    Nicoletti, F
    [J]. CLINICAL NEUROPHARMACOLOGY, 2002, 25 (01) : 21 - 24
1